Concentrated insulins: the new basal insulins

Concentrated insulins: the new basal insulins

Bibliographic Details
Main Authors:	Lamos, Elizabeth M, Younk, Lisa M, Davis, Stephen N
Format:	Online
Language:	English
Published:	Dove Medical Press 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790523/

Similar Items

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
by: Nasrallah, Sami N., et al.
Published: (2012)

Future of newer basal insulin
by: Madhu, S. V., et al.
Published: (2013)

Degludec insulin: A novel basal insulin
by: Kalra, Sanjay, et al.
Published: (2011)

Cardiovascular effects of basal insulins
by: Mannucci, Edoardo, et al.
Published: (2015)

Lixisenatide as add-on therapy to basal insulin
by: Brown, Dominique Xavier, et al.
Published: (2013)

Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps
by: Holterhus, Paul-Martin, et al.
Published: (2013)

Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
by: Kalra, Sanjay
Published: (2013)

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial
by: Davies, M. J., et al.
Published: (2016)

Basal Insulin Use With GLP-1 Receptor Agonists
by: Anderson, Sarah L., et al.
Published: (2016)

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
by: Rodrigo Oliveira Moreira, et al.
Published: (2018-04-01)

Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump
by: Kuroda, Akio, et al.
Published: (2011)

In search of the ideal basal insulin: Does the new‐generation ultra‐long‐acting insulin, degludec, provide the answer?
by: Hui, Elaine, et al.
Published: (2013)

An Overview of Concentrated Insulin Products
by: Painter, Nathan A., et al.
Published: (2016)

Concepts and clinical use of ultra-long basal insulin
by: Eliaschewitz, Freddy Goldberg, et al.
Published: (2016)

The metabolic and mitogenic properties of basal insulin analogues
by: Tennagels, Norbert, et al.
Published: (2013)

Modern basal insulin analogs: An incomplete story
by: Singh, Awadhesh Kumar, et al.
Published: (2014)

Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
by: Pfohl, Martin, et al.
Published: (2015)

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
by: Riddle, Matthew, et al.
Published: (2009)

Methods for concentration of urinary immunoreactive insulin.
by: Du, B. H., et al.
Published: (1986)

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes
by: Bergenstal, Richard M., et al.
Published: (2012)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
by: Boronat, Mauro, et al.
Published: (2015)

Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A1 chieve study
by: Bhattacharyya, Arpandev, et al.
Published: (2014)

Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials
by: Rosenstock, Julio, et al.
Published: (2016)

Melatonin modifies basal and stimulated insulin secretion via NADPH oxidase
by: Simões, D., et al.
Published: (2016)

Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
by: Tosaka, Yuka, et al.
Published: (2015)

Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
by: Boucher-Berry, Claudia, et al.
Published: (2016)

Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods
by: Chow, Nelson, et al.
Published: (2016)

Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose‐lowering effects
by: Haahr, Hanne, et al.
Published: (2016)

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
by: Abe, Shinya, et al.
Published: (2011)

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
by: TSAI, Shih-Tzer, et al.
Published: (2011)

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
by: Wang, Fei, et al.
Published: (2012)

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
by: Jonassen, Ib, et al.
Published: (2012)

Insulin glargine versus other types of basal insulin–clinical and tumor characteristics in patients with breast carcinoma
by: Besic, Nikola, et al.
Published: (2013)

Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen
by: Haddad, Jihad, et al.
Published: (2013)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
by: Trevor J. Orchard, et al.
Published: (2017-06-01)

Treatment intensification using long-acting insulin –predictors of future basal insulin supported oral therapy in the DIVE registry
by: Danne, Thomas, et al.
Published: (2015)

Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart
by: Havelund, Svend, et al.
Published: (2015)

Meta-analysis of insulin aspart versus regular human insulin used in a basal–bolus regimen for the treatment of diabetes mellitus
by: Heller, Simon, et al.
Published: (2013)

Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma Patients
by: Anderwald, Christian-Heinz, et al.
Published: (2013)

Insulin concentrations used in in vitro embryo production systems: a pilot study on insulin stability with an emphasis on concentrations measured in vivo
by: Laskowski, Denise, et al.
Published: (2016)